VIACYTE INC.

Profile

Company Names

VIACYTE INC.

Addresses

3550 GENERAL ATOMICS COURT, SAN DIEGO, CA 92121

Phone Numbers

8584553708

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$149,561,373.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-04-06 
$53,931,166.00 
$58,506,166.00 
$4,575,000.00 
Equity 
4
2020-03-20 
$32,645,780.00 
$36,018,634.00 
$3,372,854.00 
Equity 
3
2018-11-16 
$35,833,603.00 
$90,021,103.00 
$54,187,500.00 
Equity 
2
2014-08-08 
$15,000,000.00 
$15,000,000.00 
$0.00 
Debt 
1
2013-07-08 
$12,150,824.00 
$27,175,642.00 
$15,024,818.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
R. 
ALTMAN 
DIRECTOR
VIACYTE INC.   |  DEXCOM INC
BRITTANY 
 
BRADRICK 
EXECUTIVE OFFICER
VIACYTE INC.   |  DERMATA THERAPEUTICS, INC.
ELIZABETH 
 
BUI 
EXECUTIVE OFFICER
VIACYTE INC.   |  METRO AT 1515 LLC
LIZ 
 
BUI 
EXECUTIVE OFFICER
NOVOCELL, INC   |  VIACYTE INC.
KEVIN 
 
D-AMOUR 
EXECUTIVE OFFICER
VIACYTE INC.   |  BROOKLYN IMMUNOTHERAPEUTICS, INC.
DONALD 
J. 
ELMER 
DIRECTOR
NOVOCELL, INC   |  VIACYTE INC.
MARK 
G. 
FOLETTA 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  VIACYTE INC.
HOWARD 
 
FOYT 
EXECUTIVE OFFICER
VIACYTE INC.
PAUL 
 
HASTINGS 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  RELYPSA INC   |  NKARTA, INC.   |  VIACYTE INC.
LUCIAN 
 
IANCOVICI 
DIRECTOR
RALLYBIO HOLDINGS, LLC   |  VIACYTE INC.   |  CERIBELL, INC.   |  RALLYBIO CORP
FRANKLIN 
P. 
JOHNSON 
DIRECTOR
NOVOCELL, INC   |  VIACYTE INC.
ORVILLE 
G. 
KOLTERMAN 
DIRECTOR
NOVOCELL, INC   |  VIACYTE INC.   |  GLYSENS INC
ADAM 
 
KOPPEL 
DIRECTOR
BROOKSIDE II CAYMAN LTD   |  BROOKSIDE CAPITAL PARTNERS FUND II, L.P.   |  BROOKSIDE CAPITAL PARTNERS FUND LP   |  BROOKSIDE CAYMAN LTD   |  BROOKSIDE CAYMAN PA LTD   |  PTC THERAPEUTICS, INC.   |  VIACYTE INC.   |  SOLID BIOSCIENCES INC.   |  CARDURION PHARMACEUTICALS, INC.   |  ARETEIA THERAPEUTICS, INC.
STEVE 
 
KRADJIAN 
EXECUTIVE OFFICER
VIACYTE INC.
PAUL 
 
LAIKIND 
EXECUTIVE OFFICER, DIRECTOR
VIACYTE INC.
HEATH 
 
LUKATCH 
DIRECTOR
INOGEN INC   |  ANAPTYSBIO INC   |  CIANNA MEDICAL INC   |  ELEVATION PHARMACEUTICALS INC   |  FLEXION THERAPEUTICS INC   |  SPINIFEX PHARMACEUTICALS INC   |  SATSUMA PHARMACEUTICALS, INC.   |  ADYNXX, INC.   |  ENGAGE THERAPEUTICS, INC.   |  VIEWPOINT THERAPEUTICS, INC.   |  HALO NEURO INC.   |  SUTROVAX, INC.   |  VIACYTE INC.   |  CARGO THERAPEUTICS, INC.   |  MAGNUS MEDICAL, INC.
FRED 
A. 
MIDDLETON 
DIRECTOR
ENDOCYTE INC   |  NOVOCELL, INC   |  CYLENE PHARMACEUTICALS, INC.   |  LINEAGEN INC   |  AXIKIN PHARMACEUTICALS INC   |  STEREOTAXIS, INC.   |  VIACYTE INC.   |  LINEAGEN, INC   |  CHIMERIX INC   |  MESA VERDE VENTURE PARTNERS IV, LP   |  THERAVIDA, INC.
SANDRA 
 
POOLE 
DIRECTOR
VIACYTE INC.   |  MYTHIC THERAPEUTICS, INC.
ALLAN 
 
ROBIN 
EXECUTIVE OFFICER
VIACYTE INC.
ALLAN 
 
ROBINS 
EXECUTIVE OFFICER
NOVOCELL, INC   |  VIACYTE INC.
ANNE 
 
SANDAN 
EXECUTIVE OFFICER
VIACYTE INC.
MICHAEL 
 
SCOTT 
EXECUTIVE OFFICER
GLOBALONE FINANCIAL, INC.   |  COMANCHERO CORP   |  PREFERRED SPECTRUM INVESTMENTS, LLC   |  VUZIX CORP   |  VIACYTE INC.   |  SAFEBRAIN SYSTEMS, INC.   |  FARMSTEAD PARTNERS, LP   |  NEW STATE CAPITAL PARTNERS FUND, LP   |  NEW STATE CAPITAL PARTNERS FRIENDS + FAMILY CO-INVESTMENT FUND, LP   |  TRINITY MOTION PICTURE CONTENT FUND I, LLC   |  ESALT MEDIA TECHNOLOGIES, LLC   |  SAMMARTINO INVESTMENTS LLC   |  TERRAMERA, INC.   |  AMERICAN SOUTHERN HOMES HOLDINGS, LLC   |  DERIVE VENTURES FUND I, LP   |  CANVASBACK OIL + GAS, LP   |  GOLDENEYE MINERALS, LP   |  TIP OPPORTUNITY I, LLC   |  EKKL LLC
IAN 
 
SMITH 
DIRECTOR
CARGURUS LLC   |  CROSSHAIR EXPLORATION + MINING CORP   |  YELLOWHEAD MINING INC.   |  MAX RESOURCE CORP.   |  FUNKY EYES INTERNATIONAL, INC.   |  XAPO HOLDINGS LTD   |  CATHEDRAL LAKE II, LTD.   |  CATHEDRAL LAKE III, LTD.   |  CATHEDRAL LAKE CLO 2013, LTD.   |  FOODTRUCKR, LLC   |  AURORA INNOVATION, INC.   |  CARGURUS, INC.   |  VIACYTE INC.   |  SANATANA RESOURCES INC   |  SOLID BIOSCIENCES INC.   |  AURORA INNOVATION, INC.   |  ODYSSEY THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.
STEVE 
 
WHITE 
EXECUTIVE OFFICER
LAKE MARY PROJECT #1 JOINT VENTURE   |  SVAYA NANOTECHNOLOGIES, INC.   |  CLARIVOY, INC.   |  HARVEST HEALTH + RECREATION INC.   |  VIACYTE INC.
ASISH 
 
XAVIER 
DIRECTOR
CELLADON CORP   |  AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  ISCIENCE INTERVENTIONAL CORP   |  ISCIENCE INTERVENTIONAL CORP   |  CATALYST BIOSCIENCES INC   |  GENOCEA BIOSCIENCES, INC.   |  ALDEXA THERAPEUTICS, INC.   |  E-SCAPE BIO, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  VIACYTE INC.   |  ADICET BIO, INC.   |  ESCAPE BIO, INC.   |  IMMPACT BIO USA INC.   |  PAIGE.AI, INC.   |  SONOTHERA, INC.   |  BRIGHT PEAK THERAPEUTICS, INC.
ASISH 
K. 
XAVIER 
DIRECTOR
PROTAGONIST THERAPEUTICS INC   |  VIACYTE INC.   |  PHASEBIO PHARMACEUTICALS INC
MICHAEL 
 
YANG 
EXECUTIVE OFFICER, DIRECTOR
BECOME INC   |  CLOSELY, INC.   |  PADOPOLIS, INC.   |  NINTHDECIMAL, INC.   |  KIWI CRATE INC.   |  SABH-S BIG ADVENTURE INC.   |  VIACYTE INC.   |  CLEARCOVER, INC.   |  JADE HEALTHCARE, INC.   |  99 COUNTIES, INC.   |  REITLER OPPORTUNITY CAPITAL FUND II, L.P.
AMIR 
 
ZAMANI 
DIRECTOR
VIACYTE INC.
MARK 
 
ZIMMERMAN 
EXECUTIVE OFFICER
VIACYTE INC.   |  PHENIX SOLUTIONS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-04-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-04-06 
2020-04-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-20 
2018-12-03
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-11-16 
2014-08-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2014-08-08 
2013-07-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
RAYMOND JAMES + ASSOCIATES, INC.
705